Skip to content
HW211019 22646 Innate Killer Summit 2022 logo

This event ran in San Diego on
March 30 – April 1, 2022
Get updates for the 2023 version

Check out the EU edition of this meeting!
Innate Killer Summit Europe

  • Home
  • About
    • About the Innate Killer Summit
    • Media Hub
  • What’s On
    • Full Event Guide
    • Speakers
  • Partnerships
    • Partnership Opportunities
    • Partners
    • Media Partners
  • Take Part
    • Register Interest
    • Contact Us

Avectas

By kanita | 10th March 2021

Avectas is a cell engineering business focused on improving the cost, manufacturing and patient outcomes for the next generation of cellular therapies. Avectas is developing a unique delivery technology platform, Solupore®, to enable the ex-vivo manufacture of gene modified cell therapy products, with partners. Solupore® is a patented, non-viral, cell engineering technology that permeabilizes the target cell membrane and allows efficient transfer of cargo into cells whilst retaining very high levels of cell viability and functionality. The Solupore® technology is designed for use with mRNA, DNA, and proteins, including gene editing tools such as CRISPR. Solupore® achieves excellent engineering efficiencies for delivery of these payloads to primary T cells and NK cells for immuno-oncology and gene editing applications. Avectas is currently developing the clinical (cGMP) technology embodiment while enhancing its dataset, implementing its commercialization strategy and building out the team.

OUR CONTACT DETAILS

T: + 1 415 735 3289
E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

EVENT DETAILS

Returning in 2023

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.